Alpha Cognition Inc ACOG 深 沪
等待开盘 07-25 09:30:00 美东时间
7.90
-0.330
-4.01%
华盛通- 最 高8.48
- 今 开8.23
- 成交量 2.83万股
- 最 低 7.60
- 昨 收 8.23
- 总市值 1.72亿
- 52周最高 10.10
- 市盈率 静 --
- 换手率 0.13%
- 52周最低 4.50
- 委 比 -55.75%
- 总股本 2177.41万
- 历史最高 11.54
- 量 比 0.16
- 振 幅 10.69%
- 历史最低 3.75
- 每 手 1
- 风险率 1.28%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Alpha Cognition’s RESOLVE Study: Fresh Real‑World Data on Zunveyl in Alzheimer’s Care
Alpha Cognition Inc ($ACOG) announced an update on their ongoing clinical study...
07-21 00:30
美股大行评级 | 潜在涨幅98.68%！DA Davidson上调Almonty Industries目标价至33美元，维持"买入"评级
今日重点评级关注：DA Davidson：维持Almonty Industries"买入"评级，目标价从25美元升至33美元；Stifel：维持Nurix Therapeutics"买入"评级，目标价从34美元升至40美元
07-13 10:13
Raymond James Initiates Coverage On Alpha Cognition with Outperform Rating, Announces Price Target of $20
Raymond James analyst Ryan Deschner initiates coverage on Alpha Cognition (NASDAQ:ACOG) with a Outperform rating and announces Price Target of $20.
07-10 18:53
Alpha Cognition Appoints Robert Wills As Board Chairman, Succeeding Len Mertz
Alpha Cognition Inc. (Nasdaq: ACOG) ("Alpha Cognition", or the "Company"), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced changes to its Board of Directors. Robert Wills has been elected Chairman of the Board, succeedin...
06-23 20:35
Alpha Cognition Reports Top-Line Results From BEACON Real-World Study Of ZUNVEYL
Providers reported cognitive improvement in 92% of patients following initiation of ZUNVEYLProviders reported improvement in neuropsychiatric symptoms in 93% of patients after initiation of ZUNVEYLProviders
06-09 20:05
美股大行评级 | Susquehanna上调美光目标价从600美元升至1750美元；戴尔、MongoDB、网泰信息存储、Nextpower、Okta等获多家大行上调目标价
今日重点评级关注：Ascendiant Capital：维持Aclarion"买入"评级，目标价从7美元升至7.5美元；Susquehanna：维持美光科技"积极"评级，目标价从600美元升至1750美元
06-01 14:11
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers INVO Fertility (NASDAQ:IVF) shares increased by 33.0% to $2.5 during F...
05-30 05:05
Maxim Group Initiates Coverage On Alpha Cognition with Buy Rating, Announces Price Target of $12
Maxim Group analyst Naz Rahman initiates coverage on Alpha Cognition (NASDAQ:ACOG) with a Buy rating and announces Price Target of $12.
05-29 21:47
电话会总结 ｜ Alpha Cognition(ACOG)2026财年Q1业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Alpha Cognition业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** 2026年第一季度实现净产品收入350万美元，较2025年第四季度的250万美元环比增长40%。与2025年第一季度的34.7万美元相比，同比大幅增长，但需注意2025年第一季度仅包含3月最后两周的商业化收入。 **盈利状况：** 净亏损650万美元，合每股亏损0.30美元，较2025年第一季度净亏损170万美元（每股亏损0.11美元）同比扩大。 **运营费用：** 总运营费用（含收入成本）约1160万美元，较2025年第四季度的1070
05-15 12:08
